BRCA1:基底类乳腺癌中未被识别的血统可塑性的调节器
Rahul Sanawar1,2,3,4, Satheesh Kumar Sengodan5
1Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY, 10461, USA. rahul.sanawar@einsteinmed.edu.
Journal of mammary gland biology and neoplasia
|December 3, 2025
概括
BRCA1突变驱动了激进的基底样乳腺癌 (BLBC),因为它导致光原始细胞变成基底样细胞. 这种血统可塑性为BRCA1突变乳腺癌提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 基底类乳腺癌 (BLBC) 是具有侵略性,缺乏ER,PR和HER2,预后不佳.
- BRCA1突变与BLBC发育,较大的瘤和更高等级瘤密切相关.
- 乳腺癌中BRCA1损失的细胞起源和血统特异性影响尚不清楚.
研究的目的:
- 为了研究BRCA1在乳腺上皮层内的血统可塑性中的作用.
- 了解BRCA1损失如何影响细胞层次和分化.
- 为了确定BRCA1突变乳腺癌的潜在治疗点.
主要方法:
- 使用了基因工程小鼠模型.
- 使用了谱系追踪实验.
- 分析了乳腺细胞层次和分化.
主要成果:
- BRCA1功能丧失导致光原体的异常分化为基底类细胞.
- 这表明BLBC可能起源于错误调节的光区.
- 缺少BRCA1会改变乳腺细胞层次.
结论:
- 在乳腺上皮细胞中,BRCA1在维持血统忠实性方面发挥着至关重要的作用.
- 通过BRCA1介导的谱系可塑性是BLBC瘤发生的关键机制.
- 针对这些机制为BRCA1突变乳腺癌提供了新的治疗策略.
关键词:
BC- 乳腺癌 - 乳腺癌BLBC-基底类乳腺癌-类似基底类乳腺癌.BRCA1- (B 乳腺癌基因 1)在ER-雌激素受体.HER2-人类表皮生长因子受体2MaSC-乳腺干细胞 乳腺干细胞PR- 孕激素受体的受体TNBC- 三重阴性乳腺癌更多相关视频
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Lineage Commitment
4.0K
Commitment is the process whereby stem cells:
4.0K


